down arrow

Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
267.05
20.15 (8.16%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Panacea Biotec
Sun Pharma.Inds.
Torrent Pharma
Alembic
Morepen Labs.
Guj. Themis Bio.
Senores Pharma.
Mankind Pharma
Suven Life Scie.
Why is Gujarat Themis Biosyn Ltd ?
1
Flat results in Dec 24
  • NO KEY NEGATIVE TRIGGERS
2
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 09-Apr-25 and has generated 2.29% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROE of 23.6, it has a Very Expensive valuation with a 12 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -3.95%, its profits have fallen by -4.2%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guj. Themis Bio. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Guj. Themis Bio.
1.56%
-0.07
54.20%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.53%
EBIT Growth (5y)
29.43%
EBIT to Interest (avg)
60.45
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.23
Tax Ratio
25.18%
Dividend Payout Ratio
36.63%
Pledged Shares
3.30%
Institutional Holding
2.65%
ROCE (avg)
55.97%
ROE (avg)
42.39%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
51
Industry P/E
33
Price to Book Value
12.04
EV to EBIT
39.09
EV to EBITDA
36.40
EV to Capital Employed
12.38
EV to Sales
17.30
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
31.40%
ROE (Latest)
23.57%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...